Learn more

EXOSOME DIAGNOSTICS INC

Overview
  • Total Patents
    130
  • GoodIP Patent Rank
    14,108
  • Filing trend
    ⇩ 53.0%
About

EXOSOME DIAGNOSTICS INC has a total of 130 patent applications. It decreased the IP activity by 53.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, measurement and organic fine chemistry are FOCUS DIAGNOSTICS INC, NIPPON GENE CO LTD and SERACARE LIFE SCIENCES INC.

Patent filings per year

Chart showing EXOSOME DIAGNOSTICS INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Skog Johan Karl Olov 90
#2 Noerholm Mikkel 54
#3 Enderle Daniel 34
#4 Yan Haoheng 29
#5 Russo Leileata M 28
#6 Ramachandran Aparna 28
#7 Berghoff Emily 28
#8 Wei Tai-Fen 22
#9 Skog Johan 19
#10 Comper Wayne 18

Latest patents

Publication Filing date Title
WO2021055770A2 Compositions, methods, and kits for the isolation of extracellular vesicles
WO2020263926A1 Sample collection device and methods of using same
WO2020106853A1 Compositions and methods for internal controls of microvesicle isolations
WO2019236853A1 Methods for developing urine biomarkers and for detecting bladder cancer
US2020224245A1 Sequencing of nucleic acids associated with exosomal isolation from patients with glioblastoma multiforme
CN111133106A Method for isolating and enriching extracellular vesicles from biological fluid sources and methods of use thereof
CN110945145A Microvesicle nucleic acids and/or proteins and their use as markers for renal transplant rejection
US2020149036A1 Methods to distinguish rna and dna in a combined preparation
WO2018119455A1 Biofluid analysis and quantitation systems and methods
EP3548635A1 Methods to detect mutations in plasma using exosomal rna and cell free dna from non-small cell lung cancer patients
WO2018076018A1 Sequencing and analysis of exosome associated nucleic acids
CN109642229A Extracellular vesica is separated from biofluid and isolates the automatically and manually method of Cell-free DNA
EP3452613A1 Profiling microvesicle nucleic acids and uses thereof as signatures in diagnosis of renal transplant rejection
WO2017185086A1 Devices and methods for in vivo capture of biological samples and nucleic acids therein
US2019093172A1 Plasma-based detection of anaplastic lymphoma kinase (alk) nucleic acids and alk fusion transcripts and uses thereof in diagnosis and treatment of cancer
EP3200922A1 Apparatuses, methods, and systems for sample collection and dispersion
US2017211139A1 Compositions and methods for detecting rare sequence variants in nucleic acid sequencing
AU2015287763A1 Methods for isolating microvesicles and extracting nucleic acids from biological samples
EP3495509A1 Urine biomarker cohorts, gene expression signatures, and methods of use thereof
AU2014216135A1 A novel EGFR variant